Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: After-Hours Movers » 18:32
01/31/23
01/31
18:32
01/31/23
18:32
CACC

Credit Acceptance

$463.21 /

+10.05 (+2.22%)

, OI

O-I Glass

$19.24 /

+0.49 (+2.61%)

, SYK

Stryker

$253.76 /

+4.245 (+1.70%)

, EW

Edwards Lifesciences

$76.70 /

+0.57 (+0.75%)

, AMD

AMD

$75.19 /

+2.76 (+3.81%)

, MDLZ

Mondelez

$65.46 /

+0.595 (+0.92%)

, JSPR

Jasper Therapeutics

$1.70 /

-0.04 (-2.30%)

, SNAP

Snap

$11.56 /

+0.43 (+3.86%)

, HA

Hawaiian Holdings

$12.32 /

+0.555 (+4.72%)

, EA

Electronic Arts

$128.56 /

-0.47 (-0.36%)

, MTCH

Match Group

$54.07 /

+1.69 (+3.23%)

, WDC

Western Digital

$43.90 /

-0.3449 (-0.78%)

, VREX

Varex Imaging

$21.52 /

+0.66 (+3.16%)

, JNPR

Juniper

$32.26 /

+0.135 (+0.42%)

, SMCI

Super Micro Computer

$72.30 /

+0.19 (+0.26%)

, ASH

Ashland

$109.22 /

+2.51 (+2.35%)

, HLI

Houlihan Lokey

$98.63 /

+0.64 (+0.65%)

, TSHA

Taysha Gene Therapies

$1.63 /

+0.0901 (+5.85%)

, PSTX

Poseida Therapeutics

$6.97 /

+0.2701 (+4.03%)

Check out this evening's…

ShowHide Related Items >><<
WDC Western Digital
$43.90 /

-0.3449 (-0.78%)

TSHA Taysha Gene Therapies
$1.63 /

+0.0901 (+5.85%)

SYK Stryker
$253.76 /

+4.245 (+1.70%)

SNAP Snap
$11.56 /

+0.43 (+3.86%)

SMCI Super Micro Computer
$72.30 /

+0.19 (+0.26%)

PSTX Poseida Therapeutics
$6.97 /

+0.2701 (+4.03%)

OI O-I Glass
$19.24 /

+0.49 (+2.61%)

MTCH Match Group
$54.07 /

+1.69 (+3.23%)

MDLZ Mondelez
$65.46 /

+0.595 (+0.92%)

JSPR Jasper Therapeutics
$1.70 /

-0.04 (-2.30%)

JNPR Juniper
$32.26 /

+0.135 (+0.42%)

HLI Houlihan Lokey
$98.63 /

+0.64 (+0.65%)

HA Hawaiian Holdings
$12.32 /

+0.555 (+4.72%)

EW Edwards Lifesciences
$76.70 /

+0.57 (+0.75%)

EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

CACC Credit Acceptance
$463.21 /

+10.05 (+2.22%)

ASH Ashland
$109.22 /

+2.51 (+2.35%)

AMD AMD
$75.19 /

+2.76 (+3.81%)

CACC Credit Acceptance
$463.21 /

+10.05 (+2.22%)

11/03/22 BMO Capital
Credit Acceptance price target lowered to $364 from $477 at BMO Capital
11/02/22 Credit Suisse
Credit Acceptance price target lowered to $410 from $430 at Credit Suisse
08/02/22 Credit Suisse
Credit Acceptance price target lowered to $440 from $460 at Credit Suisse
05/03/22 Credit Suisse
Credit Acceptance price target raised to $460 from $440 at Credit Suisse
OI O-I Glass
$19.24 /

+0.49 (+2.61%)

01/09/23 Wells Fargo
O-I Glass upgraded to Overweight from Equal Weight at Wells Fargo
01/04/23 Citi
O-I Glass upgraded to Buy from Neutral at Citi
11/14/22 Barclays
O-I Glass price target raised to $13 from $12 at Barclays
10/13/22 BofA
O-I Glass price target lowered to $17 from $18 at BofA
SYK Stryker
$253.76 /

+4.245 (+1.70%)

01/25/23 KeyBanc
Stryker initiated with a Sector Weight at KeyBanc
01/09/23 RBC Capital
Stryker upgraded to Outperform from Sector Perform at RBC Capital
01/04/23 Barclays
Stryker price target raised to $265 from $257 at Barclays
01/03/23 Evercore ISI
Stryker price target raised to $265, added to 'TAP Outperform' list at Evercore
EW Edwards Lifesciences
$76.70 /

+0.57 (+0.75%)

01/31/23 Bernstein
Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein
01/30/23 Piper Sandler
Edwards Lifesciences downgraded to Neutral from Overweight at Piper Sandler
12/12/22 Canaccord
Edwards Lifesciences price target lowered to $73 from $78 at Canaccord
12/12/22 Citi
Edwards Lifesciences price target lowered to $92 from $99 at Citi
AMD AMD
$75.19 /

+2.76 (+3.81%)

01/30/23 Morgan Stanley
Intel's quarter points to some risk for AMD in Q1, says Morgan Stanley
01/30/23 Susquehanna
AMD price target raised to $88 from $80 at Susquehanna
01/27/23 BofA
Intel price target lowered to $25 from $28 at BofA
01/27/23 Barclays
Intel price target lowered to $27 from $30 at Barclays
MDLZ Mondelez
$65.46 /

+0.595 (+0.92%)

01/06/23 Mizuho
Mondelez price target raised to $78 from $75 at Mizuho
01/03/23 Wells Fargo
Mondelez initiated with an Overweight at Wells Fargo
01/03/23 RBC Capital
Mondelez downgraded to Sector Perform from Outperform at RBC Capital
12/20/22 Morgan Stanley
Mondelez price target raised to $75 from $69 at Morgan Stanley
JSPR Jasper Therapeutics
$1.70 /

-0.04 (-2.30%)

11/14/22 Oppenheimer
Jasper Therapeutics price target lowered to $8 from $21 at Oppenheimer
10/31/22 EF Hutton
Jasper Therapeutics initiated with a Buy at EF Hutton
02/28/22 Cantor Fitzgerald
Jasper Therapeutics initiated with an Overweight at Cantor Fitzgerald
02/28/22 Cantor Fitzgerald
Jasper Therapeutics initiated with an Overweight at Cantor Fitzgerald
SNAP Snap
$11.56 /

+0.43 (+3.86%)

01/20/23 MKM Partners
MKM Partners cuts Pinterest to Neutral, sees balanced risk-reward
01/19/23 JPMorgan
JPMorgan calls out Meta as top pick ahead of earnings from online ads group
01/18/23 OTR Global
Snap downgraded to Mixed from Positive view at OTR Global
01/17/23 JMP Securities
Snap downgraded to Market Perform from Outperform at JMP Securities
HA Hawaiian Holdings
$12.32 /

+0.555 (+4.72%)

12/20/22 Deutsche Bank
Hawaiian Holdings price target lowered to $13 from $17 at Deutsche Bank
12/16/22 Goldman Sachs
Hawaiian Holdings resumed with a Sell at Goldman Sachs
10/06/22 BofA
Hawaiian Holdings price target lowered to $10 from $12 at BofA
08/15/22 Melius Research
Hawaiian Holdings initiated with a Hold at Melius Research
EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

01/27/23 Wedbush
Electronic Arts initiated with an Outperform at Wedbush
01/27/23 Credit Suisse
Electronic Arts price target raised to $154 from $143 at Credit Suisse
01/25/23 Barclays
Electronic Arts price target raised to $132 from $130 at Barclays
01/17/23 Benchmark
Electronic Arts price target lowered to $150 from $188 at Benchmark
MTCH Match Group
$54.07 /

+1.69 (+3.23%)

01/31/23 Piper Sandler
Match Group turnaround bumpier than hoped, says Piper Sandler
01/30/23 Deutsche Bank
Match Group price target raised to $65 from $60 at Deutsche Bank
01/26/23 Citi
Match Group initiated with a Neutral at Citi
01/25/23 Barclays
Match Group price target raised to $52 from $50 at Barclays
WDC Western Digital
$43.90 /

-0.3449 (-0.78%)

01/23/23 Exane BNP Paribas
Western Digital upgraded to Neutral from Underperform at Exane BNP Paribas
01/06/23 Benchmark
Western Digital upgraded to Hold at Benchmark after Kioxia merger talks report
01/06/23 Benchmark
Western Digital upgraded to Hold from Sell at Benchmark
01/05/23 Deutsche Bank
Western Digital, Kioxia deal makes 'a lot of sense,' says Deutsche Bank
VREX Varex Imaging
$21.52 /

+0.66 (+3.16%)

10/12/22 Jefferies
Varex Imaging initiated with a Hold at Jefferies
JNPR Juniper
$32.26 /

+0.135 (+0.42%)

01/17/23 Piper Sandler
Juniper price target raised to $32 from $31 at Piper Sandler
12/20/22 JPMorgan
JPMorgan ups Juniper target, adds to Analyst Focus List
12/13/22 Morgan Stanley
Juniper price target raised to $29 from $25 at Morgan Stanley
10/26/22 Piper Sandler
Juniper price target raised to $31 from $29 at Piper Sandler
SMCI Super Micro Computer
$72.30 /

+0.19 (+0.26%)

01/11/23 Northland
Super Micro short report presents attractive entry point, says Northland
12/29/22 Northland
Super Micro Computer named a top pick entering 2023 at Northland
11/02/22 Northland
Super Micro Computer price target raised to $165 from $137 at Northland
11/02/22 Wedbush
Super Micro Computer price target raised to $65 from $55 at Wedbush
ASH Ashland
$109.22 /

+2.51 (+2.35%)

01/26/23 BMO Capital
Ashland price target lowered to $135 from $139 at BMO Capital
01/26/23 Mizuho
Ashland price target lowered to $136 from $141 at Mizuho
11/09/22 Deutsche Bank
Ashland price target raised to $125 from $120 at Deutsche Bank
11/09/22 Wells Fargo
Ashland price target raised to $118 from $104 at Wells Fargo
HLI Houlihan Lokey
$98.63 /

+0.64 (+0.65%)

01/02/23 Keefe Bruyette
Houlihan Lokey price target raised to $95 from $90 at Keefe Bruyette
07/18/22 Morgan Stanley
Houlihan Lokey upgraded to Equal Weight from Underweight at Morgan Stanley
07/08/22 Piper Sandler
Houlihan Lokey price target lowered to $78 from $80 at Piper Sandler
04/07/22 Piper Sandler
Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
TSHA Taysha Gene Therapies
$1.63 /

+0.0901 (+5.85%)

01/27/23 Morgan Stanley
Taysha Gene Therapies downgraded at Morgan Stanley on management uncertainty
01/27/23 Morgan Stanley
Taysha Gene downgraded to Equal Weight from Overweight at Morgan Stanley
01/19/23 JMP Securities
Taysha Gene Therapies price target lowered to $6 from $20 at JMP Securities
11/14/22 Wells Fargo
Taysha Gene Therapies price target lowered to $14 from $20 at Wells Fargo
PSTX Poseida Therapeutics
$6.97 /

+0.2701 (+4.03%)

01/04/23 H.C. Wainwright
Poseida Therapeutics initiated with a Buy at H.C. Wainwright
12/28/22 Cantor Fitzgerald
Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks
11/11/22 BTIG
Poseida Therapeutics price target lowered to $14 from $20 at BTIG
08/09/22 Piper Sandler
Poseida Therapeutics price target raised to $11 from $9 at Piper Sandler
WDC Western Digital
$43.90 /

-0.3449 (-0.78%)

VREX Varex Imaging
$21.52 /

+0.66 (+3.16%)

TSHA Taysha Gene Therapies
$1.63 /

+0.0901 (+5.85%)

SYK Stryker
$253.76 /

+4.245 (+1.70%)

SNAP Snap
$11.56 /

+0.43 (+3.86%)

SMCI Super Micro Computer
$72.30 /

+0.19 (+0.26%)

PSTX Poseida Therapeutics
$6.97 /

+0.2701 (+4.03%)

OI O-I Glass
$19.24 /

+0.49 (+2.61%)

MTCH Match Group
$54.07 /

+1.69 (+3.23%)

MDLZ Mondelez
$65.46 /

+0.595 (+0.92%)

JSPR Jasper Therapeutics
$1.70 /

-0.04 (-2.30%)

JNPR Juniper
$32.26 /

+0.135 (+0.42%)

HLI Houlihan Lokey
$98.63 /

+0.64 (+0.65%)

HA Hawaiian Holdings
$12.32 /

+0.555 (+4.72%)

EW Edwards Lifesciences
$76.70 /

+0.57 (+0.75%)

EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

CACC Credit Acceptance
$463.21 /

+10.05 (+2.22%)

ASH Ashland
$109.22 /

+2.51 (+2.35%)

AMD AMD
$75.19 /

+2.76 (+3.81%)

  • 25
    Jan
  • 27
    Oct
  • 04
    Aug
WDC Western Digital
$43.90 /

-0.3449 (-0.78%)

SNAP Snap
$11.56 /

+0.43 (+3.86%)

MTCH Match Group
$54.07 /

+1.69 (+3.23%)

MDLZ Mondelez
$65.46 /

+0.595 (+0.92%)

JNPR Juniper
$32.26 /

+0.135 (+0.42%)

HLI Houlihan Lokey
$98.63 /

+0.64 (+0.65%)

EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

AMD AMD
$75.19 /

+2.76 (+3.81%)

WDC Western Digital
$43.90 /

-0.3449 (-0.78%)

TSHA Taysha Gene Therapies
$1.63 /

+0.0901 (+5.85%)

SYK Stryker
$253.76 /

+4.245 (+1.70%)

SNAP Snap
$11.56 /

+0.43 (+3.86%)

SMCI Super Micro Computer
$72.30 /

+0.19 (+0.26%)

OI O-I Glass
$19.24 /

+0.49 (+2.61%)

MTCH Match Group
$54.07 /

+1.69 (+3.23%)

MDLZ Mondelez
$65.46 /

+0.595 (+0.92%)

JNPR Juniper
$32.26 /

+0.135 (+0.42%)

HA Hawaiian Holdings
$12.32 /

+0.555 (+4.72%)

EW Edwards Lifesciences
$76.70 /

+0.57 (+0.75%)

EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

AMD AMD
$75.19 /

+2.76 (+3.81%)

WDC Western Digital
$43.90 /

-0.3449 (-0.78%)

SYK Stryker
$253.76 /

+4.245 (+1.70%)

SNAP Snap
$11.56 /

+0.43 (+3.86%)

SMCI Super Micro Computer
$72.30 /

+0.19 (+0.26%)

MTCH Match Group
$54.07 /

+1.69 (+3.23%)

MDLZ Mondelez
$65.46 /

+0.595 (+0.92%)

JSPR Jasper Therapeutics
$1.70 /

-0.04 (-2.30%)

JNPR Juniper
$32.26 /

+0.135 (+0.42%)

EW Edwards Lifesciences
$76.70 /

+0.57 (+0.75%)

EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

AMD AMD
$75.19 /

+2.76 (+3.81%)

Earnings
Houlihan Lokey reports Q3 adjusted EPS $1.14, consensus $1.15 » 16:17
01/31/23
01/31
16:17
01/31/23
16:17
HLI

Houlihan Lokey

$98.63 /

+0.64 (+0.65%)

Reports Q3 revenue $456M,…

Reports Q3 revenue $456M, consensus $479.19M. "Houlihan Lokey continues to operate in a challenging M&A environment, which negatively impacted our third quarter fiscal 2023 results. However, once again the firm distinguished itself in the industry in calendar year 2022. I am proud to announce that in 2022 we were recognized as the #1 M&A advisor globally based on number of completed transactions, the #1 restructuring advisor globally based on both the number of completed transactions and value, and the #1 most active fairness opinion advisor by volume for the past 25 years, per Refinitiv. The firm is well poised to continue its long term growth profile when the market dynamics improve." stated Scott Beiser, Chief Executive Officer of Houlihan Lokey.

ShowHide Related Items >><<
HLI Houlihan Lokey
$98.63 /

+0.64 (+0.65%)

HLI Houlihan Lokey
$98.63 /

+0.64 (+0.65%)

01/02/23 Keefe Bruyette
Houlihan Lokey price target raised to $95 from $90 at Keefe Bruyette
07/18/22 Morgan Stanley
Houlihan Lokey upgraded to Equal Weight from Underweight at Morgan Stanley
07/08/22 Piper Sandler
Houlihan Lokey price target lowered to $78 from $80 at Piper Sandler
04/07/22 Piper Sandler
Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
HLI Houlihan Lokey
$98.63 /

+0.64 (+0.65%)

HLI Houlihan Lokey
$98.63 /

+0.64 (+0.65%)

Recommendations
Houlihan Lokey price target raised to $95 from $90 at Keefe Bruyette » 20:54
01/02/23
01/02
20:54
01/02/23
20:54
HLI

Houlihan Lokey

$87.13 /

-1.53 (-1.73%)

Keefe Bruyette analyst…

Keefe Bruyette analyst Matthew Moon raised the firm's price target on Houlihan Lokey to $95 from $90 and keeps a Market Perform rating on the shares after taking over coverage of the name. The analyst is entering 2023 with a market-weight position on the M&A independents group. He sees near-term value in companies with higher relative exposure to hi top three identified themes: U.S.-based M&A, restructuring, and strategically rather than sponsor driven deals. Against this backdrop, Moon's top picks for the space are Evercore and PJT Partners (PJT). Alternatively, Lazard's (LAZ) higher relative European M&A exposure as well as continued concerns on its asset management business, Moelis' (MC) high sponsor exposure, and Greenhill & Co.'s (GHL) continued comp and headcount pressure warrant Underperform ratings, Moon tells investors in a research note. The analyst also offers a "tactical pair-trade idea" of overweight PJT, underweight Perella Weinberg Partners (PWP).

ShowHide Related Items >><<
HLI Houlihan Lokey
$87.13 /

-1.53 (-1.73%)

HLI Houlihan Lokey
$87.13 /

-1.53 (-1.73%)

07/18/22 Morgan Stanley
Houlihan Lokey upgraded to Equal Weight from Underweight at Morgan Stanley
07/08/22 Piper Sandler
Houlihan Lokey price target lowered to $78 from $80 at Piper Sandler
04/07/22 Piper Sandler
Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
04/07/22 Wolfe Research
PJT Partners upgraded to Outperform from Peer Perform at Wolfe Research
HLI Houlihan Lokey
$87.13 /

-1.53 (-1.73%)

HLI Houlihan Lokey
$87.13 /

-1.53 (-1.73%)

HLI Houlihan Lokey
$87.13 /

-1.53 (-1.73%)

Over a quarter ago
Hot Stocks
Houlihan Lokey has agreed to acquire independent advisory firm Oakley Advisory » 08:05
11/14/22
11/14
08:05
11/14/22
08:05
HLI

Houlihan Lokey

$96.09 /

+0.11 (+0.11%)

Houlihan Lokey has…

Houlihan Lokey has agreed to acquire Oakley Advisory, an independent advisory firm that provides a range of services to clients across the digital infrastructure, communications services, and cloud landscape. This transaction adds substantially to Houlihan Lokey's global coverage of the digital infrastructure sector and significantly augments the existing sector coverage in Europe. Oakley Advisory was formed in 2015 by Managing Partners Chris Godsmark and Christian Maher, who for the previous eight years had built up the firm as Oakley Capital Corporate Finance. The Oakley Advisory team has an industry heritage of more than two decades and provides clients with a full suite of sector specialist services, including private and public company M&A, equity and debt fundraisings, and IPO advisory. To date, the team has completed more than 150 transactions with a combined deal value of over GBP 35 billion and has a large international network of client relationships with corporates, listed companies, private equity funds, infrastructure funds, and family offices. As part of this transaction, Chris Godsmark and Christian Maher join Houlihan Lokey as Managing Directors to spearhead the expansion of the firm's market-leading digital infrastructure coverage into Europe.

ShowHide Related Items >><<
HLI Houlihan Lokey
$96.09 /

+0.11 (+0.11%)

HLI Houlihan Lokey
$96.09 /

+0.11 (+0.11%)

07/18/22 Morgan Stanley
Houlihan Lokey upgraded to Equal Weight from Underweight at Morgan Stanley
07/08/22 Piper Sandler
Houlihan Lokey price target lowered to $78 from $80 at Piper Sandler
04/07/22 Piper Sandler
Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
04/07/22 Wolfe Research
PJT Partners upgraded to Outperform from Peer Perform at Wolfe Research
HLI Houlihan Lokey
$96.09 /

+0.11 (+0.11%)

HLI Houlihan Lokey
$96.09 /

+0.11 (+0.11%)

HLI Houlihan Lokey
$96.09 /

+0.11 (+0.11%)

Hot Stocks
Houlihan Lokey CEO Beiser sells $1.5M in company shares » 17:18
11/09/22
11/09
17:18
11/09/22
17:18
HLI

Houlihan Lokey

$91.81 /

-1.93 (-2.06%)

CEO of Houlihan Loke…

CEO of Houlihan Loke Scott Beiser sold 16,367 shares of company stock at $93.28 per share on November 7, for a total transaction amount of $1,526,714.

ShowHide Related Items >><<
HLI Houlihan Lokey
$91.81 /

-1.93 (-2.06%)

HLI Houlihan Lokey
$91.81 /

-1.93 (-2.06%)

07/18/22 Morgan Stanley
Houlihan Lokey upgraded to Equal Weight from Underweight at Morgan Stanley
07/08/22 Piper Sandler
Houlihan Lokey price target lowered to $78 from $80 at Piper Sandler
04/07/22 Piper Sandler
Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
04/07/22 Wolfe Research
PJT Partners upgraded to Outperform from Peer Perform at Wolfe Research
HLI Houlihan Lokey
$91.81 /

-1.93 (-2.06%)

HLI Houlihan Lokey
$91.81 /

-1.93 (-2.06%)

HLI Houlihan Lokey
$91.81 /

-1.93 (-2.06%)

Earnings
Houlihan Lokey reports Q2 adjusted EPS $1.19, consensus $1.03 » 16:22
10/27/22
10/27
16:22
10/27/22
16:22
HLI

Houlihan Lokey

$83.31 /

+0.99 (+1.20%)

Reports Q2 revenue…

Reports Q2 revenue $489.54M, consensus $432.65M. "Our second quarter results reflect the benefit of our diversified business model. In a challenging market environment, growth in Financial Restructuring and Financial and Valuation Advisory partly offset headwinds in our Corporate Finance business. We are proud to note that our Financial and Valuation Advisory business recorded its second-best quarter ever, as we continue to grow that business across all service lines. Market conditions for Financial Restructuring continue to improve and we see potential that this cycle may produce an elevated level of restructuring revenues over an extended period of time. In Corporate Finance, despite difficult year-over-year comparisons, we are starting to see an increase in deal closings leading into the second half of the fiscal year, and the quality of our new deal activity continues to improve. We remain confident the Firm is well positioned across various types of macro-economic environments" stated Scott Beiser, CEO of Houlihan Lokey.

ShowHide Related Items >><<
HLI Houlihan Lokey
$83.31 /

+0.99 (+1.20%)

HLI Houlihan Lokey
$83.31 /

+0.99 (+1.20%)

07/18/22 Morgan Stanley
Houlihan Lokey upgraded to Equal Weight from Underweight at Morgan Stanley
07/08/22 Piper Sandler
Houlihan Lokey price target lowered to $78 from $80 at Piper Sandler
04/07/22 Piper Sandler
Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
04/07/22 Wolfe Research
PJT Partners upgraded to Outperform from Peer Perform at Wolfe Research
HLI Houlihan Lokey
$83.31 /

+0.99 (+1.20%)

HLI Houlihan Lokey
$83.31 /

+0.99 (+1.20%)

HLI Houlihan Lokey
$83.31 /

+0.99 (+1.20%)

Periodicals
Bausch Health taps advisers to help it map out future, WSJ reports » 17:00
08/22/22
08/22
17:00
08/22/22
17:00
BHC

Bausch Health

$5.59 /

+0.145 (+2.66%)

, HLI

Houlihan Lokey

$81.30 /

-3.74 (-4.40%)

Bausch Health (BHC) has…

Bausch Health (BHC) has tapped advisers to help it figure out the future of the company after it lost a major patent dispute and has attracted controversy over the recent spinoff of its eye-care unit, the Wall Street Journal's Alexander Saeedy reports. The company has retained law firm White & Case LLP and investment bank Houlihan Lokey (HLI) to advise it on strategic options going forward, the author notes. Reference Link

ShowHide Related Items >><<
HLI Houlihan Lokey
$81.30 /

-3.74 (-4.40%)

BHC Bausch Health
$5.59 /

+0.145 (+2.66%)

BHC Bausch Health
$5.59 /

+0.145 (+2.66%)

07/29/22 RBC Capital
Bausch Health downgraded to Sector Perform from Outperform at RBC Capital
07/29/22 RBC Capital
Bausch Health downgraded to Sector Perform from Outperform at RBC Capital
07/28/22 Truist
Bausch Health downgraded to Hold from Buy at Truist
07/28/22 Stifel
Stifel puts Bausch rating under review amid 'significant confusion'
HLI Houlihan Lokey
$81.30 /

-3.74 (-4.40%)

07/18/22 Morgan Stanley
Houlihan Lokey upgraded to Equal Weight from Underweight at Morgan Stanley
07/08/22 Piper Sandler
Houlihan Lokey price target lowered to $78 from $80 at Piper Sandler
04/07/22 Piper Sandler
Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
04/07/22 Wolfe Research
PJT Partners upgraded to Outperform from Peer Perform at Wolfe Research
HLI Houlihan Lokey
$81.30 /

-3.74 (-4.40%)

BHC Bausch Health
$5.59 /

+0.145 (+2.66%)

HLI Houlihan Lokey
$81.30 /

-3.74 (-4.40%)

BHC Bausch Health
$5.59 /

+0.145 (+2.66%)

HLI Houlihan Lokey
$81.30 /

-3.74 (-4.40%)

BHC Bausch Health
$5.59 /

+0.145 (+2.66%)

BHC Bausch Health
$5.59 /

+0.145 (+2.66%)

Earnings
Houlihan Lokey reports Q1 EPS $1.03, consensus 94c » 16:26
07/28/22
07/28
16:26
07/28/22
16:26
HLI

Houlihan Lokey

$84.95 /

+2.53 (+3.07%)

Reports Q1 revenue…

Reports Q1 revenue $418.6M, consensus $396.9M. "We had a solid first fiscal quarter and our diversified business model is performing as we would expect it to in the face of current market conditions. We are seeing a slowdown in global M&A closings; however, new business activity in both our corporate finance and financial and valuation advisory business segments remains healthy. Furthermore, we are beginning to experience a meaningful increase in distressed business opportunities. Regardless of the business environment we encounter in the coming quarters, we believe we are well positioned to successfully address a variety of market conditions," stated Scott Beiser, CEO.

ShowHide Related Items >><<
HLI Houlihan Lokey
$84.95 /

+2.53 (+3.07%)

HLI Houlihan Lokey
$84.95 /

+2.53 (+3.07%)

07/18/22 Morgan Stanley
Houlihan Lokey upgraded to Equal Weight from Underweight at Morgan Stanley
07/08/22 Piper Sandler
Houlihan Lokey price target lowered to $78 from $80 at Piper Sandler
04/07/22 Piper Sandler
Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
04/07/22 Wolfe Research
PJT Partners upgraded to Outperform from Peer Perform at Wolfe Research
HLI Houlihan Lokey
$84.95 /

+2.53 (+3.07%)

HLI Houlihan Lokey
$84.95 /

+2.53 (+3.07%)

HLI Houlihan Lokey
$84.95 /

+2.53 (+3.07%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:00
07/18/22
07/18
10:00
07/18/22
10:00
YUM

Yum! Brands

$119.14 /

+1.17 (+0.99%)

, JPM

JPMorgan

$114.88 /

+1.98 (+1.75%)

, BWA

BorgWarner

$35.18 /

+1.56 (+4.64%)

, HLI

Houlihan Lokey

$79.12 /

+1.32 (+1.70%)

, EXFY

Expensify

$19.85 /

+2.34 (+13.36%)

, GM

General Motors

$33.32 /

+0.46 (+1.40%)

, GT

Goodyear Tire

$10.92 /

-0.12 (-1.09%)

, PARA

Paramount

$24.29 /

-0.72 (-2.88%)

, FOXA

Fox Corp.

$33.17 /

-0.515 (-1.53%)

, FOX

Fox Corp.

$30.64 /

-0.395 (-1.27%)

, EAT

Brinker

$22.91 /

-0.08 (-0.35%)

, CMG

Chipotle

$1,315.00 /

+16.19 (+1.25%)

, MC

Moelis

$41.43 /

+0.63 (+1.54%)

, BL

BlackLine

$65.85 /

-2.62 (-3.83%)

, KHC

Kraft Heinz

$38.65 /

+0.615 (+1.62%)

, PEN

Penumbra

$122.66 /

+0.09 (+0.07%)

, DICE

Dice Therapeutics

$16.30 /

+0.37 (+2.32%)

, CVRX

CVRx

$7.23 /

+0.43 (+6.32%)

, OYST

Oyster Point Pharma

$4.47 /

+ (+0.00%)

Institutional investors…

ShowHide Related Items >><<
YUM Yum! Brands
$119.14 /

+1.17 (+0.99%)

PARA Paramount
$24.29 /

-0.72 (-2.88%)

OYST Oyster Point Pharma
$4.47 /

+ (+0.00%)

KHC Kraft Heinz
$38.65 /

+0.615 (+1.62%)

JPM JPMorgan
$114.88 /

+1.98 (+1.75%)

HLI Houlihan Lokey
$79.12 /

+1.32 (+1.70%)

GT Goodyear Tire
$10.92 /

-0.12 (-1.09%)

GM General Motors
$33.32 /

+0.46 (+1.40%)

FOXA Fox Corp.
$33.17 /

-0.515 (-1.53%)

FOX Fox Corp.
$30.64 /

-0.395 (-1.27%)

EXFY Expensify
$19.85 /

+2.34 (+13.36%)

EAT Brinker
$22.91 /

-0.08 (-0.35%)

DICE Dice Therapeutics
$16.30 /

+0.37 (+2.32%)

CVRX CVRx
$7.23 /

+0.43 (+6.32%)

CMG Chipotle
$1,315.00 /

+16.19 (+1.25%)

BWA BorgWarner
$35.18 /

+1.56 (+4.64%)

BL BlackLine
$65.85 /

-2.62 (-3.83%)

YUM Yum! Brands
$119.14 /

+1.17 (+0.99%)

07/18/22 Morgan Stanley
Yum! Brands price target lowered to $142 from $146 at Morgan Stanley
07/18/22 Goldman Sachs
Yum! Brands upgraded to Buy from Sell at Goldman Sachs
06/09/22 Barclays
Yum! Brands price target lowered to $120 from $124 at Barclays
05/06/22 Guggenheim
Domino's Pizza price target lowered to $370 from $445 at Guggenheim
JPM JPMorgan
$114.88 /

+1.98 (+1.75%)

07/18/22 Berenberg
JPMorgan upgraded to Hold from Sell at Berenberg
07/15/22 RBC Capital
JPMorgan price target lowered to $130 from $155 at RBC Capital
07/15/22 Evercore ISI
JPMorgan price target lowered to $125 from $135 at Evercore ISI
07/15/22 Oppenheimer
JPMorgan price target lowered to $153 from $154 at Oppenheimer
BWA BorgWarner
$35.18 /

+1.56 (+4.64%)

07/18/22 Deutsche Bank
BorgWarner upgraded to Buy from Hold at Deutsche Bank
06/01/22 Goldman Sachs
BorgWarner price target lowered to $40 from $41 at Goldman Sachs
06/01/22 Morgan Stanley
BorgWarner price target lowered to $30 from $32 at Morgan Stanley
05/05/22 Wells Fargo
BorgWarner price target lowered to $52 from $57 at Wells Fargo
HLI Houlihan Lokey
$79.12 /

+1.32 (+1.70%)

07/18/22 Morgan Stanley
Houlihan Lokey upgraded to Equal Weight from Underweight at Morgan Stanley
07/08/22 Piper Sandler
Houlihan Lokey price target lowered to $78 from $80 at Piper Sandler
04/07/22 Piper Sandler
Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
04/07/22 Wolfe Research
PJT Partners upgraded to Outperform from Peer Perform at Wolfe Research
EXFY Expensify
$19.85 /

+2.34 (+13.36%)

07/18/22 BofA
BofA upgrades 'category disruptor' Expensify to Buy with $25 target
07/18/22 BofA
Expensify upgraded to Buy from Neutral at BofA
06/15/22 JPMorgan
Expensify price target lowered to $30 from $47 at JPMorgan
05/13/22 Citi
Expensify price target lowered to $21 from $27 at Citi
GM General Motors
$33.32 /

+0.46 (+1.40%)

07/18/22 Deutsche Bank
Deutsche downgrades GM to Hold on growing earnings risk
07/18/22 Deutsche Bank
General Motors downgraded to Hold from Buy at Deutsche Bank
07/14/22 Morgan Stanley
General Motors price target lowered to $42 from $44 at Morgan Stanley
07/05/22 Barclays
General Motors Q2 earnings estimate cut at Barclays
GT Goodyear Tire
$10.92 /

-0.12 (-1.09%)

07/18/22 Deutsche Bank
Goodyear Tire downgraded to Hold from Buy at Deutsche Bank
05/16/22 Citi
Goodyear Tire price target lowered to $15 from $19 at Citi
05/10/22 Nomura
Goodyear Tire upgraded to Buy at Nomura after 48% year-to-date decline
05/10/22 Nomura
Goodyear Tire upgraded to Buy from Neutral at Nomura
PARA Paramount
$24.29 /

-0.72 (-2.88%)

07/18/22 Morgan Stanley
Paramount downgraded to Underweight from Equal Weight at Morgan Stanley
07/14/22 Barclays
Paramount price target lowered to $20 from $24 at Barclays
07/07/22 Citi
Paramount price target lowered to $37 from $44 at Citi
07/06/22 BofA
Paramount price target lowered to $28 from $32 at BofA
FOXA Fox Corp.
$33.17 /

-0.515 (-1.53%)

07/18/22 Morgan Stanley
Fox Corp. downgraded to Equal Weight from Overweight at Morgan Stanley
05/25/22 Deutsche Bank
Fox Corp. price target lowered to $46 from $48 at Deutsche Bank
04/19/22 Rosenblatt
Fox Corp. initiated with a Neutral at Rosenblatt
04/12/22 Vertical Group
Fox Corp. upgraded to Positive from Mixed at Vertical Group
FOX Fox Corp.
$30.64 /

-0.395 (-1.27%)

06/02/22 Wolfe Research
Fox Corp. assumed at Peer Perform from Outperform at Wolfe Research
12/14/21 Macquarie
Fox Corp. price target lowered to $37 from $40 at Macquarie
08/05/21 Guggenheim
Guggenheim upgrades Fox Corp. to Buy, maintains $41 price target
EAT Brinker
$22.91 /

-0.08 (-0.35%)

07/18/22 Morgan Stanley
Brinker price target lowered to $26 from $37 at Morgan Stanley
07/18/22 Goldman Sachs
Brinker downgraded to Neutral from Buy at Goldman Sachs
07/08/22 Wedbush
Wedbush sees Dine Brands, Wingsstop, Wendy's as Best Ideas in restaurants
06/27/22 BofA
Brinker reinstated with an Underperform at BofA
CMG Chipotle
$1,315.00 /

+16.19 (+1.25%)

07/18/22 Morgan Stanley
Chipotle price target lowered to $1,768 from $1,904 at Morgan Stanley
07/18/22 Goldman Sachs
Chipotle downgraded to Buy from Conviction Buy at Goldman Sachs
07/14/22 Oppenheimer
Chipotle price target lowered to $1,725 from $1,925 at Oppenheimer
MC Moelis
$41.43 /

+0.63 (+1.54%)

07/18/22 Morgan Stanley
Moelis downgraded to Underweight from Equal Weight at Morgan Stanley
07/11/22 Wolfe Research
Moelis downgraded to Underperform from Peer Perform at Wolfe Research
07/08/22 Piper Sandler
Moelis price target lowered to $45 from $50 at Piper Sandler
07/06/22 UBS
Moelis downgraded to Neutral from Buy at UBS
BL BlackLine
$65.85 /

-2.62 (-3.83%)

07/18/22 BofA
BlackLine downgraded to Underperform at BofA on risk to premium valuation
07/18/22 BofA
BlackLine downgraded to Underperform from Neutral at BofA
05/06/22 BTIG
BlackLine price target lowered to $95 from $115 at BTIG
05/06/22 JPMorgan
BlackLine price target lowered to $70 from $75 at JPMorgan
KHC Kraft Heinz
$38.65 /

+0.615 (+1.62%)

07/18/22 Deutsche Bank
Kraft Heinz price target lowered to $47 from $48 at Deutsche Bank
07/18/22 Mizuho
Kraft Heinz initiated with a Buy at Mizuho
06/22/22 BMO Capital
Kraft Heinz upgraded to Outperform from Market Perform at BMO Capital
05/26/22 UBS
UBS cuts Kraft Heinz to Sell, sees private label trade-down risk not priced in
PEN Penumbra
$122.66 /

+0.09 (+0.07%)

07/18/22 BTIG
Penumbra price target lowered to $213 from $272 at BTIG
07/18/22 RBC Capital
Penumbra initiated with an Outperform at RBC Capital
05/17/22 Citi
Penumbra price target lowered to $220 from $280 at Citi
05/04/22 Wells Fargo
Penumbra price target lowered to $265 from $321 at Wells Fargo
DICE Dice Therapeutics
$16.30 /

+0.37 (+2.32%)

07/18/22 H.C. Wainwright
Dice Therapeutics initiated with a Buy at H.C. Wainwright
10/11/21 SVB Securities
Dice Therapeutics initiated with an Outperform at SVB Leerink
10/11/21 Evercore ISI
Evercore ISI starts Dice Therapeutics at Outperform, sees 120% upside
10/11/21 BofA
Dice Therapeutics initiated with a Buy at BofA
CVRX CVRx
$7.23 /

+0.43 (+6.32%)

07/18/22 Craig-Hallum
CVRx initiated with a Buy at Craig-Hallum
02/16/22 Piper Sandler
CVRx pullback brings 'excellent entry point,' says Piper Sandler
01/14/22 Piper Sandler
Piper tells small cap investors to buy basket of recent med tech IPOs
01/13/22 Canaccord
CVRx price target lowered to $17 from $30 at Canaccord
OYST Oyster Point Pharma
$4.47 /

+ (+0.00%)

07/18/22 H.C. Wainwright
Oyster Point Pharma initiated with a Buy at H.C. Wainwright
05/27/22 Piper Sandler
Oyster Point Pharma price target lowered to $15 from $60 at Piper Sandler
02/08/22 Piper Sandler
Piper Sandler lowers 2022 sales estimate for Oyster Point's Tyrvaya
11/09/21 JPMorgan
Oyster Point downgraded to Neutral on estimate risk at JPMorgan
YUM Yum! Brands
$119.14 /

+1.17 (+0.99%)

PEN Penumbra
$122.66 /

+0.09 (+0.07%)

PARA Paramount
$24.29 /

-0.72 (-2.88%)

OYST Oyster Point Pharma
$4.47 /

+ (+0.00%)

MC Moelis
$41.43 /

+0.63 (+1.54%)

KHC Kraft Heinz
$38.65 /

+0.615 (+1.62%)

JPM JPMorgan
$114.88 /

+1.98 (+1.75%)

HLI Houlihan Lokey
$79.12 /

+1.32 (+1.70%)

GT Goodyear Tire
$10.92 /

-0.12 (-1.09%)

GM General Motors
$33.32 /

+0.46 (+1.40%)

FOXA Fox Corp.
$33.17 /

-0.515 (-1.53%)

EXFY Expensify
$19.85 /

+2.34 (+13.36%)

EAT Brinker
$22.91 /

-0.08 (-0.35%)

CVRX CVRx
$7.23 /

+0.43 (+6.32%)

CMG Chipotle
$1,315.00 /

+16.19 (+1.25%)

BWA BorgWarner
$35.18 /

+1.56 (+4.64%)

BL BlackLine
$65.85 /

-2.62 (-3.83%)

  • 18
    Nov
  • 16
    Nov
  • 10
    Nov
  • 15
    Sep
YUM Yum! Brands
$119.14 /

+1.17 (+0.99%)

PARA Paramount
$24.29 /

-0.72 (-2.88%)

KHC Kraft Heinz
$38.65 /

+0.615 (+1.62%)

JPM JPMorgan
$114.88 /

+1.98 (+1.75%)

HLI Houlihan Lokey
$79.12 /

+1.32 (+1.70%)

GT Goodyear Tire
$10.92 /

-0.12 (-1.09%)

GM General Motors
$33.32 /

+0.46 (+1.40%)

FOXA Fox Corp.
$33.17 /

-0.515 (-1.53%)

FOX Fox Corp.
$30.64 /

-0.395 (-1.27%)

EAT Brinker
$22.91 /

-0.08 (-0.35%)

CMG Chipotle
$1,315.00 /

+16.19 (+1.25%)

BL BlackLine
$65.85 /

-2.62 (-3.83%)

YUM Yum! Brands
$119.14 /

+1.17 (+0.99%)

PARA Paramount
$24.29 /

-0.72 (-2.88%)

MC Moelis
$41.43 /

+0.63 (+1.54%)

KHC Kraft Heinz
$38.65 /

+0.615 (+1.62%)

JPM JPMorgan
$114.88 /

+1.98 (+1.75%)

HLI Houlihan Lokey
$79.12 /

+1.32 (+1.70%)

GT Goodyear Tire
$10.92 /

-0.12 (-1.09%)

GM General Motors
$33.32 /

+0.46 (+1.40%)

FOXA Fox Corp.
$33.17 /

-0.515 (-1.53%)

EXFY Expensify
$19.85 /

+2.34 (+13.36%)

EAT Brinker
$22.91 /

-0.08 (-0.35%)

CMG Chipotle
$1,315.00 /

+16.19 (+1.25%)

BWA BorgWarner
$35.18 /

+1.56 (+4.64%)

BL BlackLine
$65.85 /

-2.62 (-3.83%)

PARA Paramount
$24.29 /

-0.72 (-2.88%)

KHC Kraft Heinz
$38.65 /

+0.615 (+1.62%)

JPM JPMorgan
$114.88 /

+1.98 (+1.75%)

GT Goodyear Tire
$10.92 /

-0.12 (-1.09%)

GM General Motors
$33.32 /

+0.46 (+1.40%)

FOXA Fox Corp.
$33.17 /

-0.515 (-1.53%)

EXFY Expensify
$19.85 /

+2.34 (+13.36%)

EAT Brinker
$22.91 /

-0.08 (-0.35%)

DICE Dice Therapeutics
$16.30 /

+0.37 (+2.32%)

CVRX CVRx
$7.23 /

+0.43 (+6.32%)

CMG Chipotle
$1,315.00 /

+16.19 (+1.25%)

BWA BorgWarner
$35.18 /

+1.56 (+4.64%)

Upgrade
Houlihan Lokey upgraded to Equal Weight from Underweight at Morgan Stanley » 07:09
07/18/22
07/18
07:09
07/18/22
07:09
HLI

Houlihan Lokey

$77.90 /

+2.865 (+3.82%)

Morgan Stanley analyst…

Morgan Stanley analyst Manan Gosalia upgraded Houlihan Lokey to Equal Weight from Underweight with a price target of $82, down from $95. Houlihan Lokey's multiple has held up better than peers during prior recession fears as a skew to the counter-cyclical restructuring business and less volatile Financial & Valuation Advisory business makes them a more defensive play, said Gosalia, who expects "this time should be no different." Houlihan Lokey also typically sees more opportunity to acquire smaller boutique advisors during downturns, which drives more revenue upside when the cycle turns, the analyst added.

ShowHide Related Items >><<
HLI Houlihan Lokey
$77.90 /

+2.865 (+3.82%)

HLI Houlihan Lokey
$77.90 /

+2.865 (+3.82%)

07/08/22 Piper Sandler
Houlihan Lokey price target lowered to $78 from $80 at Piper Sandler
04/07/22 Piper Sandler
Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
04/07/22 Wolfe Research
PJT Partners upgraded to Outperform from Peer Perform at Wolfe Research
03/22/22 Piper Sandler
Houlihan Lokey price target lowered to $92 from $106 at Piper Sandler
HLI Houlihan Lokey
$77.90 /

+2.865 (+3.82%)

HLI Houlihan Lokey
$77.90 /

+2.865 (+3.82%)

HLI Houlihan Lokey
$77.90 /

+2.865 (+3.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.